(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-24 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 6340
| Date | Daily Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.85 | 1.72 | 1.97 | 1.72 | 0.773 times |
| 23 Thu Jan 2025 | 1.88 | 1.85 | 1.92 | 1.72 | 0.773 times |
| 22 Wed Jan 2025 | 1.85 | 1.75 | 1.87 | 1.68 | 0.315 times |
| 21 Tue Jan 2025 | 1.81 | 1.70 | 1.82 | 1.70 | 0.883 times |
| 17 Fri Jan 2025 | 1.66 | 1.77 | 1.77 | 1.66 | 1.577 times |
| 17 Fri Jan 2025 | 1.66 | 1.77 | 1.77 | 1.66 | 1.577 times |
| 16 Thu Jan 2025 | 1.77 | 1.69 | 1.85 | 1.69 | 2.098 times |
| 15 Wed Jan 2025 | 1.81 | 1.78 | 1.83 | 1.73 | 0.221 times |
| 14 Tue Jan 2025 | 1.86 | 1.75 | 1.86 | 1.75 | 0.631 times |
| 13 Mon Jan 2025 | 1.85 | 1.82 | 1.88 | 1.72 | 1.293 times |
My analysis of stock is bearish for shortterm, and stock might move down till 1.8 or till 1.6. Use a stoploss of 1.89 and if the stock hits stoploss, then it can shoot up till 2.01
Share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Target | 1.29 |
| Downside Target | 1.42 |
| Downside Target | 1.52 |
| Downside Target | 1.62 |
| Downside Target | 1.66 |
| Downside Target | 1.77 |
| Upside Target | 1.88 |
| Upside Target | 1.97 |
| Upside Target | 2.09 |
| Upside Target | 2.24 |
| Upside Target | 2.25 |
| Upside Target | 2.29 |
| Upside Target | 2.39 |
| Upside Target | 2.50 |
| Upside Target | 2.79 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Intraday Target | 1.7 |
| Downside Intraday Target | 1.54 |
| Upside Intraday Target | 1.99 |
| Upside Intraday Target | 2.12 |
| Downside Intraday Target | 1.83 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.85 | 1.70 | 1.97 | 1.68 | 1.74 times |
| 17 Fri Jan 2025 | 1.66 | 1.77 | 1.77 | 1.66 | 0.271 times |
| 17 Fri Jan 2025 | 1.66 | 1.82 | 1.88 | 1.66 | 2.097 times |
| 10 Fri Jan 2025 | 1.86 | 1.81 | 2.00 | 1.62 | 0.454 times |
| 08 Wed Jan 2025 | 2.00 | 2.02 | 2.09 | 1.80 | 0.398 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.85 | 1.99 | 2.24 | 1.52 | 0.621 times |
| 31 Tue Dec 2024 | 2.02 | 1.88 | 2.29 | 1.42 | 0.997 times |
| 26 Tue Nov 2024 | 1.85 | 2.21 | 2.39 | 1.67 | 0.13 times |
| 31 Thu Oct 2024 | 2.24 | 2.40 | 2.50 | 1.29 | 16.172 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.77 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.77 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.